NCT05774431View on ClinicalTrials.gov

Disparities in the Proportion of Ticagrelor and Prasugrel-eligible Patients with Acute Coronary Syndrome in a Real-world Registry

CompletedOBSERVATIONAL
Enrollment

6,789

Participants

Timeline

Start Date

March 13, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Acute Myocardial Infarction
Interventions
OTHER

There was no intervention necessary.

There was no intervention necessary.

Trial Locations (1)

69120

University Hospital of Heidelberg, Heidelberg

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University Hospital Heidelberg

OTHER